Merck & Co. Inc. buy BMO Capital Markets
Start price
27.10.23
/
50%
€101.00
Target price
27.10.24
€125.02
Performance (%)
-4.06%
End price
28.10.24
€96.90
Summary
This prediction ended on 28.10.24 with a price of €96.90. With a performance of -4.06%, the BUY prediction by BMO_Capital_Markets finished with a loss. BMO_Capital_Markets has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. A total of €2.82 was paid as dividends for this prediction. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | -0.215% | -0.215% | -5.966% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by BMO_Capital_Markets for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $132.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Merck & Co. Inc.
Stopped prediction by BMO_Capital_Markets for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.50
01.11.24
01.11.24
€125.35
01.11.25
01.11.25
-20.95%
02.11.25
02.11.25
